Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Brain Tumor Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Brain Tumor Therapeuticsmarket, defines the market attractiveness level of Brain Tumor Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Brain Tumor Therapeutics industry, describes the types of Brain Tumor Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Brain Tumor Therapeutics market and the development prospects and opportunities of Brain Tumor Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Brain Tumor Therapeutics market in Chapter 13.
By Player:
Philips Healthcare
AstraZeneca
GE Healthcare
Novartis
Merck
Hitachi Medical
Roche
Novocure
DelMar Pharmaceuticals
Pfizer
By Type:
Surgery
Radiation Therapy
Targeted Therapy
Chemotherapy
Immunotherapy
By End-User:
Hospitals
Oncology Treatment Centers
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Brain Tumor Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Brain Tumor Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Brain Tumor Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Brain Tumor Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Brain Tumor Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Brain Tumor Therapeutics Consumption (2017-2022)
-
7.2 United States Brain Tumor Therapeutics Consumption (2017-2022)
-
7.3 Europe Brain Tumor Therapeutics Consumption (2017-2022)
-
7.4 China Brain Tumor Therapeutics Consumption (2017-2022)
-
7.5 Japan Brain Tumor Therapeutics Consumption (2017-2022)
-
7.6 India Brain Tumor Therapeutics Consumption (2017-2022)
-
7.7 South Korea Brain Tumor Therapeutics Consumption (2017-2022)
8 Region and Country-wise Brain Tumor Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Brain Tumor Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Brain Tumor Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Brain Tumor Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Brain Tumor Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Brain Tumor Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Brain Tumor Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Brain Tumor Therapeutics Consumption Forecast (2022-2028)
9 Global Brain Tumor Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Brain Tumor Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Surgery Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Radiation Therapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
9.2 Global Brain Tumor Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Oncology Treatment Centers Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Brain Tumor Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Brain Tumor Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Surgery Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Brain Tumor Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Oncology Treatment Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Brain Tumor Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Brain Tumor Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Brain Tumor Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Brain Tumor Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Brain Tumor Therapeutics Market Competitive Analysis
-
14.1 Philips Healthcare
-
14.1.1 Philips Healthcare Company Details
-
14.1.2 Philips Healthcare Brain Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Philips Healthcare Brain Tumor Therapeutics Product and Service
-
14.2 AstraZeneca
-
14.2.1 AstraZeneca Company Details
-
14.2.2 AstraZeneca Brain Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 AstraZeneca Brain Tumor Therapeutics Product and Service
-
14.3 GE Healthcare
-
14.3.1 GE Healthcare Company Details
-
14.3.2 GE Healthcare Brain Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 GE Healthcare Brain Tumor Therapeutics Product and Service
-
14.4 Novartis
-
14.4.1 Novartis Company Details
-
14.4.2 Novartis Brain Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis Brain Tumor Therapeutics Product and Service
-
14.5 Merck
-
14.5.1 Merck Company Details
-
14.5.2 Merck Brain Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Merck Brain Tumor Therapeutics Product and Service
-
14.6 Hitachi Medical
-
14.6.1 Hitachi Medical Company Details
-
14.6.2 Hitachi Medical Brain Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Hitachi Medical Brain Tumor Therapeutics Product and Service
-
14.7 Roche
-
14.7.1 Roche Company Details
-
14.7.2 Roche Brain Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Roche Brain Tumor Therapeutics Product and Service
-
14.8 Novocure
-
14.8.1 Novocure Company Details
-
14.8.2 Novocure Brain Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Novocure Brain Tumor Therapeutics Product and Service
-
14.9 DelMar Pharmaceuticals
-
14.9.1 DelMar Pharmaceuticals Company Details
-
14.9.2 DelMar Pharmaceuticals Brain Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 DelMar Pharmaceuticals Brain Tumor Therapeutics Product and Service
-
14.10 Pfizer
-
14.10.1 Pfizer Company Details
-
14.10.2 Pfizer Brain Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Pfizer Brain Tumor Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Brain Tumor Therapeutics
-
Figure Brain Tumor Therapeutics Picture
-
Table Global Brain Tumor Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Brain Tumor Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Brain Tumor Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Brain Tumor Therapeutics Consumption by Country (2017-2022)
-
Figure United States Brain Tumor Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Brain Tumor Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Brain Tumor Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Brain Tumor Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Brain Tumor Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Brain Tumor Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Brain Tumor Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Brain Tumor Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Brain Tumor Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Brain Tumor Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Brain Tumor Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Brain Tumor Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Brain Tumor Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Surgery Consumption and Growth Rate (2017-2022)
-
Figure Global Radiation Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Treatment Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Surgery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Treatment Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Brain Tumor Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Brain Tumor Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Philips Healthcare (Foundation Year, Company Profile and etc.)
-
Table Philips Healthcare Brain Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Philips Healthcare Brain Tumor Therapeutics Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Brain Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Brain Tumor Therapeutics Product and Service
-
Table GE Healthcare (Foundation Year, Company Profile and etc.)
-
Table GE Healthcare Brain Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GE Healthcare Brain Tumor Therapeutics Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Brain Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Brain Tumor Therapeutics Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Brain Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Brain Tumor Therapeutics Product and Service
-
Table Hitachi Medical (Foundation Year, Company Profile and etc.)
-
Table Hitachi Medical Brain Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hitachi Medical Brain Tumor Therapeutics Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Brain Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Brain Tumor Therapeutics Product and Service
-
Table Novocure (Foundation Year, Company Profile and etc.)
-
Table Novocure Brain Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novocure Brain Tumor Therapeutics Product and Service
-
Table DelMar Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table DelMar Pharmaceuticals Brain Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table DelMar Pharmaceuticals Brain Tumor Therapeutics Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Brain Tumor Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Brain Tumor Therapeutics Product and Service
-
